NASDAQ OMX

Kommande presentationer och investerarmöten i augusti och september

Dela

 

Pressmeddelande

22 augusti 2017

Kommande presentationer och investerarmöten i augusti och september

Immunicum AB (publ), First North Premier: (IMMU.ST), ett bioteknikbolag som utvecklar ny typ av immunaktiverande cancerbehandling mot ett flertal olika solida tumörformer, meddelar idag att bolagets ledning kommer att presentera bolaget vid ett flertal kommande konferenser och investerarmöten under augusti och September.

Swedish-American Life Science Summit 2017 (SALSS)
Datum: 23-25 augusti, 2017
TIdpunkt för Immunicums presentation: 25 augusti, kl 12:00
Plats: Nasdaq Stockholm, Tullvaktsvägen 15, Stockholm

Pareto Securities' 8th Annual Healthcare Conference
Datum: 7 september, 2017
Tidpunkt för Immunicums presentation: kl 12:15
Plats: Conference 7A Strandvägen 7A Stockholm

24th Annual NewsMakers in the Biotech Industry
Datum: 8 september, 2017
Tidpunkt för Immunicums presentation: kl 8:30 - 8:55 (lokal tid)
Plats: Millennium Broadway Hotel & Conference Center, New York, NY

Rodman & Renshaw 19th Annual Global Investment Conference
Datum: 10 - 12 September, 2017
Tidpunkt för Immunicums presentation: 11 september 11, kl 17:30 - 17:55 (lokal tid)
Plats: Lotte New York Palace Hotel, New York, NY

Nordic Life Science Days 2017
Datum: 12 - 14 september, 2017
Tidpunkt för Immunicums presentation:  13 september, kl 10:40
Plats: Malmömässan, Mässgatan 6, Hyllie, Malmö

RedEye Cancer Immunotherapy "Special Event"
Datum: 21 september, 2017
Tidpunkt för Immunicums presentation: ej bestämt, kommer att presenteras på Immunicums [och Redeys] webb
Plats: Redeye, Mäster Samuelsgatan 42, 10 tr, Stockholm

BioPharm America
Datum: 26 - 27 september, 2017
Tidpunkt för Immunicums presentation: ej bestämt, kommer att presenteras på Immunicums webb
Plats: Sheraton Boston Hotel, Boston, MA

17th Annual Sachs Biotech in Europe Forum
Datum: 26 - 27 september, 2017
Tidpunkt för Immunicums presentaiton:  27 september, kl 12:00
Plats: Congress Center Basel, Switzerland

För ytterligare information kontakta:

Carlos de Sousa, VD, Immunicum
Telefon: +46 (0) 31 41 50 52
E-post: info@immunicum.com

INVESTOR RELATIONS, Sverige

Helena Stångberg
Hallvarsson & Halvarsson
Telefon: + 46 709 71 12 53
E-post: helena.stangberg@halvarsson.se

INVESTOR RELATIONS och Mediakontakt, EU/USA

MacDougall Biomedical Communications
Gretchen Schweitzer eller Stephanie May
Telefon: +49 89 2424 3494 or + 49 175 571 1562
E-post: gschweitzer@macbiocom.com eller smay@macbiocom.com

Bolagets Certified Adviser är Redeye AB
Telefon: +46 (0) 8 545 013 31.
www.redeye.se

OM IMMUNICUM AB (PUBL)

Immunicum etablerar ett unikt angreppssätt inom immunonkologi genom utveckling av lagringsbara allogena cellbaserade terapier. Vårt mål är att förbättra överlevnad och livskvaliteten genom att aktivera och förstärka patientens eget immunförsvar för att bekämpa cancern. Företagets ledande produkt, ilixadencel, bestående av pro-inflammatoriska allogena dendritiska celler, har potentialen att bli en grundstomme i modern kombinationsbehandling av ett flertal olika solida tumörformer. Immunicum är grundat och baserat i Sverige och handlas offentligt på Nasdaq First North Premier. www.immunicum.com

 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Immunicum AB via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Canadian Natural Resources Limited Announces 1 Billion Barrel Production Milestone at the Athabasca Oil Sands Project19.7.2018 11:00Pressmeddelande

CALGARY, Alberta, July 19, 2018 (GLOBE NEWSWIRE) -- Canadian Natural Resources Limited ("Canadian Natural"), as operator of the Jackpine and Muskeg River mines at the Athabasca Oil Sands Project ("AOSP"), is pleased to announce that the AOSP has achieved a mined production milestone of 1 billion barrels since operations began in 2003. Canadian Natural's President Tim McKay stated, "This is a significant milestone and demonstrates the size and scale of Canada's oil sands mining operations. The oil sands, through responsible development, provide sustainable long life low decline production and significant value for stakeholders. This milestone could not have been achieved without the dedication of the employees and contractors who focus on safe, reliable operations, while minimizing our environmental footprint to ensure long term sustainable development." Canadian Natural has a 70% working interest in the AOSP along with Chevron Canada Limited (20%) and Shell Canada Limited (10%). Canadi

ForgeRock Opens Up Open Banking19.7.2018 10:00Pressmeddelande

Delivers New, Open Reference Implementation and Sandbox Directory for Developers to Test Open Banking APIs in Five Minutes or Less LONDON, July 19, 2018 (GLOBE NEWSWIRE) -- ForgeRock®, the leading platform provider of digital identity management solutions, announced today the availability of the ForgeRock Open Banking Directory. Continuing its commitment to innovation and industry leadership, ForgeRock has delivered a reference bank implementation and directory, providing a technical sandbox for organizations looking to build and test Open Banking/PSD2 APIs. The lightweight and incredibly fast test platform has been acknowledged and celebrated by the team at UK Open Banking, the Implementation Entity set up by the UK Government's Competition and Markets Authority (CMA) in 2016, to deliver Open Banking. The ForgeRock development team has created an Open Banking Technical Solution Guide on the directory. Open Banking regulations, which began coming online in the UK earlier this year, for

TradeStation International Ltd to Offer Subscription Account Featuring TradeStation Technologies' Advanced Analytical Capabilities19.7.2018 10:00Pressmeddelande

LONDON, July 19, 2018 (GLOBE NEWSWIRE) -- TradeStation International Ltd, the London-based, United Kingdom subsidiary of TradeStation Group, Inc., today announced that it is now offering European traders, investors, advisors and market analysts access to TradeStation Analytics -- a non-brokerage subscription account featuring all of the advanced analytical capabilities of the TradeStation award-winning* platform. The software subscription account, which is provided to customers directly by affiliate TradeStation Technologies, Inc., offers market participants an opportunity to join the thousands of U.S.-based TradeStation subscribers - professionals and non-professionals alike - who trust TradeStation's cutting-edge technology to perform sophisticated market analysis, identify opportunities and stay one step ahead of today's rapidly changing financial markets. This TradeStation Analytics premium subscription package includes: Market Data delivered with speed, accuracy and reliability, w

Nordea Half-year Report 201819.7.2018 09:34Pressmeddelande

COPENHAGEN, Denmark, July 19, 2018 (GLOBE NEWSWIRE) -- Paris Stock Exchange : XHFT Second Quarter Results 2018 CEO Casper von Koskull's comments on the results: "This quarter we have started to see our efforts to increase customer satisfaction bearing fruit and we see signs of improving momentum across our various businesses among both corporate and household customers. We are delivering on cost, compliance, capital and credit quality, which is the foundation for continuing to be the stable, safe and trusted banking partner of our customers today and tomorrow. In recent years, Nordea has simplified and focused its business on its core Nordic markets and customers. The planned acquisition of Gjensidige Bank is a further step on that journey. It is a profitable, growing, digital bank, and together with our strategic partnership with Gjensidige, we are creating opportunities to strengthen our position in one of our core Nordic franchises and take part of a profitable growth. We have achie

Open-Silicon and Credo Demonstrate Solutions for Deep Learning and Networking Applications at TSMC OIP and Symposium in Amsterdam19.7.2018 09:00Pressmeddelande

AMSTERDAM, The Netherlands, July 19, 2018 (GLOBE NEWSWIRE) -- Open-Silicon, a system-optimized custom SoC solution provider and long-standing member of TSMC's Value Chain Aggregator (VCA) and Design Center Alliance (DCA) programs, and Credo, a global innovation leader in Serializer-Deserializer (SerDes) technology, will participate in a joint demonstration at the TSMC 2018 Open Innovation Platform Ecosystem Forum and Technology Symposium in Amsterdam, The Netherlands. These demonstrations will illustrate the capabilities of Open-Silicon's High Bandwidth Memory (HBM2) IP subsystem and Credo's 56G SerDes IP in enabling deep learning and networking applications. Visitors will also learn about other critical IP cores required for these applications, including a RISC-V based CPU subsystem, and Interlaken IP and Ethernet IP subsystems. Open-Silicon's HBM2 IP subsystem solution, in TSMC's FinFET and CoWoS® technologies, includes an HBM2 controller, PHY and interposer I/O. It's architected and

David Crosby Announces Intent to License His Name to the Cannabis Industry18.7.2018 18:04Pressmeddelande

Music industry icon pursuing licensing partnership with a leading Cannabis company LOS ANGELES and TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- David Crosby, co-founder of two of the most successful bands in history (Crosby, Stills, Nash & Young, and The Byrds) today announced he is seeking a licensing relationship with a national or global Cannabis company. This opportunity would include the exclusive license of his iconic name and marks for use worldwide. Mr. Crosby suggests calling the brand "MIGHTY CROZ" because his friends, colleagues and fans call him "Croz", but specific naming and packaging will be determined in consultation with the selected Cannabis company. Mr. Crosby will actively advise the selected Cannabis company in developing and marketing the brand. "People have been asking me to do a quality Cannabis brand and with legalization expanding, now is the right time," said David Crosby from his ranch in California. "Our first priority is partnering with a leading Cannabis co

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum